The Lallemand Wine app supplies winemakers with fermentation expertise with respect to Lallemand's yeast, bacteria and other microbiological products. The app also covers the range of application of these products and the best conditions for their use in wine fermentation.
The app has the following features:
• A complete microbiological product catalogue with detailed information on wine yeast, bacteria, nutrients, enzymes, and SIY for North America, South America, South Africa, and Australia/New Zealand. The catalogue supplies winemakers with the latest information on wine yeast and bacteria, nutrients, enzymes and SIY, and their range of application and the best conditions to use them.
• Lallemand's unique Wine Bacteria Sensory Profiling tool, which proposes the best solution for malolactic fermentation based on the type of wine and the desired wine style.
• A search and product filtering engine to help find products by name or by characteristic (e.g., pH, alcohol level, grape varietal, etc.)
Lallemand Inc. is a privately held Canadian company, founded at the end of the 19th century, specializing in the development, production and marketing of yeasts and bacteria for the food industry (baking, oenology, brewing, and alcohol) as well as for animal and human health and nutrition. With production plants on several continents and worldwide distribution capacities, Lallemand is the only supplier of both yeasts and bacteria on such wide scale.
Beginning in the 1970’s Lallemand focused its specialty fermentation knowledge on developing high quality dry yeast strains uniquely conceived for the worldwide wine industry. Soon after, wine bacterial strains, fermentation adjuncts and specialty inactivated yeast strains were also developed. The Lallemand range of oenology products is most widely known under the LALVIN®, UVAFERM® and ENOFERM® brand names. To this day Lallemand is still the only major supplier of yeast or bacteria that is a primary producer of both Lallemand owes its success to its continual pursuit of excellence, its flexibility and its ongoing investments in research and development.